Is Lithium Still Worth Using? An Update of Selected Recent Research

REFERENCES

• Schou M. Lithium in psychiatric therapy and prophylaxis. J Psychiatr Res 1968;6:67–95.
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press, 1990.
   Google Scholar
• Baldessarini RJ, Tondo L, Suppes T, Faedda GL, Tohen M. Pharmacological treatment of bipolar disorder throughout the life cycle. In: Shulman KI, Tohen M, Kutcher S, eds. Mood disorders across the life span. New York: Wiley-Liss, 1996:299–338.
   Google Scholar
• Baldessarini R. Drugs and the treatment of psychiatric disor- ders: antidepressant and antianxiety agents. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilman’s The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill, 2001:447–83.
   Google Scholar
• Baldessarini RJ, Tarazi FI. Drugs and the treatment of psy- chiatric disorders: antipsychotic and antimanic agents. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman and Gilman’s The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill, 2001:485–520.
   Google Scholar
• Cade JFJ. Lithium salts in the treatment of psychotic excite- ment. Med J Austral 1949;2:349–52.
   PubMed Web of Science ®Google Scholar
• Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychia- try 1994;51:8–19.
   PubMed Web of Science ®Google Scholar
• Faedda GL, Baldessarini RJ, Suppes T, Tondo L, Becker I, Lipschitz D. Pediatric-onset bipolar disorder: a neglected clinical and public health problem. Harvard Rev Psychiatry 1995;3:171–95.
   PubMed Web of Science ®Google Scholar
• Angst J. The emerging epidemiology of hypomania and bipo- lar II disorder. J Affect Disord 1998;50:143–51.
   PubMed Web of Science ®Google Scholar
• Papolos D, Papolos J. The bipolar child. New York: Broad- way, 1999.
   Google Scholar
• Sanchez L, Hagino O, Weller E, Weller R. Bipolarity in chil- dren. Psychiatr Clin North Am 1999;22:629–48.
   Web of Science ®Google Scholar
• Akiskal HS, Bourgeois ML, Angst J, Post R, Mo¨ller HJ, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar dis- orders. J Affect Disord 2000;59(suppl 1):S5–30.
   Google Scholar
• Baldessarini RJ. Plea for integrity of the bipolar disorder concept. Bipolar Disord 2000;2:3–7.
   PubMed Web of Science ®Google Scholar
• Tohen M, Hennen J, Zarate CM Jr, Baldessarini RJ, Stra- kowski SM, Stoll AL, et al. Two-year syndromal and func- tional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 2000; 157:220–8.
   Google Scholar
• Hirschfeld RM, Clayton PJ, Cohen I, Fawcett J, Keck PE Jr, McClennan J, et al. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994; 151(12, suppl):1–36.
   Google Scholar
• Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. Expert consensus guideline series: medication treatment of bipolar disorder. New York: McGraw-Hill, 2000.
   Google Scholar
• Baldessarini RJ, Tondo L. Does lithium still work? Evidence of stable responses over three decades. Arch Gen Psychiatry 2000;57:187–90.
   PubMed Web of Science ®Google Scholar
• Markar HR, Mander AJ. Efficacy of lithium prophylaxis in clinical practice. Br J Psychiatry 1989;155:496–500.
   PubMedGoogle Scholar
• Harrow M, Goldberg JF, Grossman LS, Meltzer HY. Outcome in manic disorders: a naturalistic follow-up study. Arch Gen Psychiatry 1990;47:665–71.
   PubMed Web of Science ®Google Scholar
• Grof P. Has the effectiveness of lithium changed? Impact of the variety of lithium’s effects. Neuropsychopharmacology 1998;19:183–8.
   PubMed Web of Science ®Google Scholar
• Gitlin MJ, Cochran SD, Jamison KR. Maintenance lithium treatment: side effects and compliance. J Clin Psychiatry 1989;50:127–31.
   PubMed Web of Science ®Google Scholar
• Guscott R, Taylor I. Lithium prophylaxis in recurrent af- fective illness: efficacy, effectiveness and efficiency. Br J Psy- chiatry 1994;164:741–6.
   Google Scholar
• Huxley NA, Parikh SV, Baldessarini RJ. Effectiveness of psy- chosocial treatments in bipolar disorder: state of the evi- dence. Harvard Rev Psychiatry 2000;8:126–40.
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Licht RW. Fifty years with lithium treatment in affective disorders: present problems and priorities. World J Biol Psychiatry 2001:2:18–26.
   PubMedGoogle Scholar
• Mitchell PB, Hadzi-Pavlovic D, Manji, HK, eds. Fifty years of treatment for bipolar disorder: a celebration of John Cade’s discovery. Austral NZ J Psychiatry 1999;33(suppl): S1–122.
   Google Scholar
• Licht RW. Drug treatment of mania: a critical review. Acta Psychiatr Scand 1998;97:387–97.
   PubMed Web of Science ®Google Scholar
• Davis JM, Janicak PG, Hogan DM. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis. Acta Psychiatr Scand 1999;100:406–17.
   PubMed Web of Science ®Google Scholar
• Kleindienst N, Greil W, Ru¨ ger B, Mo¨ller HJ. The prophylac- tic efficacy of lithium—transient or persistent? Eur Arch Psychiatry Clin Neurosci 1999;249:144–9.
   Google Scholar
• Centorrino F, Rendall M, Cheng E, Thirwell C, Baldessarini RJ. Trattamento farmacologico della mania acuta e della fase di mantenimento a lungo termine nel disturbo bipolare. No´os Aggiornamenti in Psichiatria 2000;6:31–75.
   Google Scholar
• Keck PE Jr, Mendl[e]wicz J, Calabrese JR, Fawcett J, Suppes T, Vestergaard PA, Carbonell C. A review of random- ized, controlled clinical trials in acute mania. J Affect Disord 2000:59(suppl 1): S31–7.
   Google Scholar
• Sachs GS, Thase ME. Bipolar disorder therapeutics: mainte- nance treatment. Biol Psychiatry 2000;48:573–81.
   PubMed Web of Science ®Google Scholar
• Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for maintenance treatment of mood dis- orders. Cochrane Database of Systematic Reviews 2001; issue 2:1–17.
   Google Scholar
• Maj M. The effect of lithium in bipolar disorder: a review of recent research evidence. Bipolar Disord [In press].
   Google Scholar
• Physicians’ desk reference. 55th ed. Montvale, New Jersey: Medical Economics, 2001.
   Google Scholar
• Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. Efficacy of divalproex vs. lithium and pla- cebo in the treatment of mania. JAMA 1994;271:918–24.
   Google Scholar
• Janicak PG, Newman RH, Davis JM. Advances in the treat- ment of manic and related disorders: a reappraisal. Psychi- atr Ann 1992;22:92–103.
   Web of Science ®Google Scholar
• McElroy SL, Keck PE Jr, Stanton SP, Tugrul KC, Bennett JA, Strakowski SM. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania. J Clin Psychiatry 1996;57:142–6.
   PubMed Web of Science ®Google Scholar
• Freeman TW, Clothier JL, Pazzaglia P, Lesem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992; 149:108–11.
   PubMed Web of Science ®Google Scholar
• Modell JG, Lenox RH, Weiner S. Inpatient clinical trial of lorazepam for the management of manic agitation. J Clin Psychopharmacol 1985;5:109–13.
   Google Scholar
• Chouinard G. Clonazepam in acute and maintenance treat- ment of bipolar affective disorder. J Clin Psychiatry 1987; 48(10, suppl):29–37.
   Google Scholar
• Bradwejn J, Shriqui C, Koszycki D, Meterissian G. Double- blind comparison of the effects of clonazepam and lorazepam in acute mania. J Clin Psychopharmacol 1990;10:403–8.
   PubMed Web of Science ®Google Scholar
• Angst J. The course of affective disorders. Psychopathology 1986;19(suppl 2):47–52.
   Google Scholar
• Zarin DA, Pass TM. Lithium and the single episode: when to begin long-term prophylaxis for bipolar disorder. Med Care 1987;25(12, suppl): S76–84.
   Google Scholar
• Viguera AC, Baldessarini RJ, Friedberg J. Discontinuing antidepressant treatment in major depression. Harvard Rev Psychiatry 1998;5:293–306.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986;7:177–88.
   PubMedGoogle Scholar
• Baastrup PC, Schou M. Lithium as a prophylactic agent: its effects against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 1967;16:162–72.
   PubMed Web of Science ®Google Scholar
• Angst J, Weis P, Grof P, Baastrup PC, Schou M. Lithium pro- phylaxis in recurrent affective disorders. Br J Psychiatry 1970;116:604–14.
   PubMed Web of Science ®Google Scholar
• Baastrup PC, Poulsen JC, Schou M, Thomsen K, Amdisen A. Prophylactic lithium: double-blind discontinuation in manic- depressive and recurrent-depressive disorders. Lancet 1970; 2:326–30.
   PubMedGoogle Scholar
• Melia PI. Prophylactic lithium: a double-blind trial in recur- rent affective disorders. Br J Psychiatry 1970;116:621–4.
   PubMedGoogle Scholar
• Coppen A, Noguera R, Bailey J, Burns BH, Swani MS, Hare EH, et al. Prophylactic lithium in affective disorders: con- trolled trial. Lancet 1971;2:275–9.
   PubMed Web of Science ®Google Scholar
• Small JG, Small IF, Moore DF. Experimental withdrawal of lithium in recovered manic-depressive patients: a report of five cases. Am J Psychiatry 1971;127:1555–8.
   Google Scholar
• Cundall RL, Brooks PW, Murray LG. A controlled evaluation of lithium prophylaxis in affective disorders. Psychol Med 1972;2:308–11.
   PubMed Web of Science ®Google Scholar
• Hullin RP, McDonald R, Allsopp MN. Prophylactic lithium in recurrent affective disorders. Lancet 1972;1:1044–6.
   PubMedGoogle Scholar
• Persson G. Lithium prophylaxis in affective disorders. Acta Psychiatr Scand 1972;48:462–79.
   Google Scholar
• Prien RF, Caffey EM Jr, Klett CJ. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Arch Gen Psy- chiatry 1973;28:337–41.
   PubMed Web of Science ®Google Scholar
• Prien RF, Klett CJ, Caffey EM Jr. Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 1973; 29:420–5.
   PubMed Web of Science ®Google Scholar
• Stallone F, Shelley E, Mendlewicz J, Fieve RR. The use of lithium in affective disorders: a double-blind study of prophy- laxis in bipolar illness. Am J Psychiatry 1973;130:1006–10.
   PubMed Web of Science ®Google Scholar
• Naylor GJ, Donald JM, Le Poidevin D, Reid AH. A double- blind trial of long-term lithium therapy in mental defectives. Br J Psychiatry 1974;124:52–7.
   PubMed Web of Science ®Google Scholar
• Prien RF, Klett CJ, Caffey EM Jr. Lithium prophylaxis in recurrent affective illness. Am J Psychiatry 1974;131:198–203.
   PubMed Web of Science ®Google Scholar
• Fieve RR, Kumbaraci T, Dunner DL. Lithium prophylaxis of depression in bipolar I, bipolar II, and unipolar patients. Am J Psychiatry 1976;133:925–9.
   PubMed Web of Science ®Google Scholar
• Fyro¨ B, Petterson U. A double-blind study of the prophylactic effect of lithium in manic-depressive disease. Acta Psychiatr Scand Suppl 1977;269:17–22.
   Google Scholar
• Holinger PC, Wolpert EA. A ten-year follow-up of lithium use. Illinois Med J 1979:156:99–104.
   Google Scholar
• Rybakowski J, Chlopocka-Wozniak M, Kapelski Z, Strzyzew- ski W. The relative prophylactic efficacy of lithium against manic and depressive recurrences in bipolar patients. Int Pharmacopsychiatry 1980;15:86–90.
   Google Scholar
• Quitkin FM, Kane JM, Rifkin A, Ramos-Lorenzi JR, Saraf K, Howard A, et al. Lithium and imipramine in the pro- phylaxis of unipolar and bipolar II depression: a prospec- tive, placebo-controlled comparison. Psychopharmacol Bull 1981;17:142–4.
   Google Scholar
• Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry 1982; 39:1065–9.
   PubMed Web of Science ®Google Scholar
• Margo A, McMahon P. Lithium withdrawal triggers psycho- sis. Br J Psychiatry 1982;141:407–10.
   PubMed Web of Science ®Google Scholar
• Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychia- try 1984;41:1096–104.
   PubMed Web of Science ®Google Scholar
• Bouman TK, Niemantsverdriet–Van Kampen JG, Ormel J, Slooff CJ. The effectiveness of lithium prophylaxis in bipolar and unipolar depressions and schizo-affective disorders. J Af- fect Disord 1986;11:275–80.
   PubMed Web of Science ®Google Scholar
• Mander AJ, Loudon JB. Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet 1988;2:15–7.
   PubMed Web of Science ®Google Scholar
• Koukopoulos A, Reginaldi D, Minnai G, Serra G, Pani L, Johnson FN. The long-term prophylaxis of affective disor- ders. Adv Biochem Psychopharmacol 1995;49:127–47.
   Google Scholar
• Maj M, Pirozzi R, Magliano L, Bartoli L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospec- tive study of 402 patients at a lithium clinic. Am J Psychia- try 1998;155:30–5.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Arch Gen Psychiatry 2000;57:481–9.
   PubMed Web of Science ®Google Scholar
• Tondo L, Baldessarini RJ, Floris G. Long-term clinical effec- tiveness of lithium maintenance treatment in types I and II bipolar disorders. Br J Psychiatry 2001;178(suppl 41): S184–90.
   Google Scholar
• Tondo L, Hennen J, Baldessarini RJ. Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 2001;104:163–72.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Chlopocka-Wozniak M, Suwalska A. The prophylactic effect of long-term lithium administration in bi- polar patients entering treatment in the 1970s and 1980s. Bipolar Disord 2001;3:63–7.
   PubMed Web of Science ®Google Scholar
• Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of re- currence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991;48:1082–8.
   PubMed Web of Science ®Google Scholar
• Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M. Outcome after rapid vs. gradual discontinuation of lithium treatment in bipolar disorders. Arch Gen Psychiatry 1993; 50:448–55.
   Google Scholar
• Suppes T, Baldessarini RJ, Faedda GL, Tondo L, Tohen M. Discontinuation of maintenance treatment in bipolar disor- der: risks and implications. Harvard Rev Psychiatry 1993; 1:131–44.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Faedda GL, Suppes TR, Floris G, Rudas N. Effects of the rate of discontinuing lithium mainte- nance treatment in bipolar disorders. J Clin Psychiatry 1996;57:441–8.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Floris G, Rudas N. Reduced mor- bidity after gradual discontinuation of lithium treatment for bipolar I and II disorders: a replication study. Am J Psychia- try 1997;154:551–3.
   Google Scholar
• Baldessarini RJ, Tondo L. Recurrence risk in bipolar manic- depressive disorders after discontinuing lithium mainte- nance treatment: an overview. Clin Drug Investig 1998;15:337–51.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L, Viguera AC. Discontinuing lithium maintenance treatment in bipolar disorders: risks and impli- cations. Bipolar Disord 1999;1:17–24.
   PubMedGoogle Scholar
• Baldessarini RJ, Suppes T, Tondo L. Lithium withdrawal in bipolar disorder: implications for clinical practice and experi- mental therapeutics research. Am J Therapeutics 1996; 3:492–6.
   PubMedGoogle Scholar
• Viguera AC, Baldessarini RJ, Hegarty JM, Van Kammen DP, Tohen M. Clinical risk following abrupt and gradual with- drawal of maintenance neuroleptic treatment. Arch Gen Psy- chiatry 1997;54:49–55.
   PubMed Web of Science ®Google Scholar
• Rosenbaum JF, Sachs GS, Lafer B, Kane JM, Keller MB, Gel enberg AJ. High rates of relapse in bipolar patients abruptly changed from standard to low plasma lithium levels in a double-blind, controlled trial. Presented at the annual meet- ing of the NIMH New Clinical Drug Evaluations Unit. Boca Raton, Florida, June 1992.
   Google Scholar
• Moncrieff J. Lithium revisited: a re-examination of the placebo-controlled trials of lithium prophylaxis in manic- depressive disorder. Br J Psychiatry 1995;167:569–73.
   PubMed Web of Science ®Google Scholar
• Moncrieff J. Lithium: evidence reconsidered. Br J Psychia- try 1997;171:113–9.
   Google Scholar
• Tondo L, Baldessarini RJ, Hennen J, Floris G. Lithium main- tenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry 1998;155:638–45.
   PubMed Web of Science ®Google Scholar
• Tondo L, Baldessarini RJ, Hennen J, Floris G, Silvetti F, To- hen M. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry 1998;59:405–14.
   Google Scholar
• Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharma- col 1993;13:397–408.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Lenox MS, Baldessarini RJ. Effectiveness and safety of long-term antidepressant treatment in bipolar dis- order. J Clin Psychiatry 2001;62:565–9.
   PubMed Web of Science ®Google Scholar
• Fieve RR, Dunner DL, Kumbaraci T, Stallone F. Lithium car- bonate prophylaxis of depression in three subtypes of pri- mary affective disorder. Pharmakopsychiatrie Neuropsycho- pharmakologie 1976;9:100–7.
   Google Scholar
• Coppen A, Ghose K, Rao R, Bailey J, Peet M. Mianserin and lithium in the prophylaxis of depression. Br J Psychiatry 1978;133:206–10.
   PubMed Web of Science ®Google Scholar
• Quitkin F, Rifkin A, Kane J, Ramos-Lorenzi JR, Klein DF. Prophylactic effect of lithium and imipramine in unipolar and bipolar II patients: a preliminary report. Am J Psychia- try 1978;135:570–2.
   Google Scholar
• Peselow ED, Dunner DL, Fieve RR, Lautin A. Lithium pro- phylaxis of depression in unipolar, bipolar II, and cyclothy- mic patients. Am J Psychiatry 1982;139:747–52.
   PubMed Web of Science ®Google Scholar
• Bauer M, Do¨pfmer S. Lithium augmentation in treatment- resistant depression: meta-analysis of placebo-controlled studies. J Clin Psychopharmacol 1999;19:427–34.
   PubMed Web of Science ®Google Scholar
• Wahlbeck K, Cheine M, Essali A, Adams C. Evidence of clo- zapine’s effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry 1999;156:990–9.
   PubMed Web of Science ®Google Scholar
• Meltzer HY, Anand R, Alphs L. Reducing suicide risk in schizophrenia: focus on the role of clozapine. CNS Drugs 2000;14:355–65.
   Web of Science ®Google Scholar
• Angst J, Sellaro R, Angst F. Long-term outcome and mortal- ity of treated versus untreated bipolar and depressed pa- tients: a preliminary report. Int J Psychiatry Clin Pract 1998;2:115–9.
   PubMedGoogle Scholar
• Baldessarini RJ, Jamison KR, eds. Effects of medical inter- ventions on suicidal behavior. J Clin Psychiatry 1999; 60(suppl 2):1–122.
   Google Scholar
• Tondo L, Jamison KR, Baldessarini RJ. Effects of lithium maintenance on suicidal behavior in major mood disorders. Ann NY Acad Sci 1997;836:339–51.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tondo L. Antisuicidal effect of lithium treat- ment in major mood disorders. In Jacobs D, ed. The Harvard Medical School guide to suicide assessment and intervention. San Francisco: Jossey-Bass, 1999:355–71.
   Google Scholar
• Tondo L, Baldessarini RJ, Hennen J, Floris G, Silvetti F, To- hen M. Lithium treatment and risk of suicidal behavior in bipolar disorder patients. J Clin Psychiatry 1998;59:405–14.
   Google Scholar
• Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treat- ment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 1999;60 (suppl 2):77–84.
   Google Scholar
• Tondo L, Baldessarini RJ. Reduced suicide risk during lith- ium maintenance treatment. J Clin Psychiatry 2000;61 (suppl 9):97–104.
   Google Scholar
• Baldessarini RJ, Tondo L, Hennen J. Treating the suicidal patient with bipolar disorder: reducing suicide risk with lith- ium. Ann NY Acad Sci 2001;932:24–43.
   PubMed Web of Science ®Google Scholar
• Coryell W, Arndt S, Turvey C, Endicott J, Solomon D, Mueller T, et al. Lithium and suicidal behavior in major af- fective disorder: a case-control study. Acta Psychiatr Scand 2001;104:193–7.
   PubMed Web of Science ®Google Scholar
• Brødersen A, Licht RW, Vestergaard P, Olesen AV, Mortensen PB. Sixteen-year mortality in patients with affective disor- der commenced on lithium. Br J Psychiatry 2000;176:429–33.
   PubMed Web of Science ®Google Scholar
• Kallner G, Lindelius R, Petterson U, Stockman O, Tham A. Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it. Pharmacopsychiatry 2000;33:8–13.
   PubMed Web of Science ®Google Scholar
• Manji HK, McNamara R, Chen G, Lenox RH. Signalling pathways in the brain: cellular transduction of mood stabili- sation in the treatment of manic-depressive illness. Austral NZ J Psychiatry 1999;33(suppl):65–83.
   Google Scholar
• Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Bald- essarini RJ. Risk of recurrence of bipolar disorder in preg- nant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000;157:179–84.
   Google Scholar
• Viguera AC, Cohen LS, Tondo L, Baldessarini RJ. Does preg- nancy reduce risk of recurrence in bipolar disorder? J Affect Disord 2001;3:245–52.
   Google Scholar
• Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML. A reevaluation of risk of in utero exposure to lithium. JAMA 1994;271:146–50.
   PubMed Web of Science ®Google Scholar
• Jeavons PM. Sodium valproate and neural tube defects [Let- ter]. Lancet 1982;2:1282–3.
   Google Scholar
• Rosa FW. Spina bifida in infants of women treated with car- bamazepine during pregnancy. N Engl J Med 1991;324:674–7.
   PubMed Web of Science ®Google Scholar
• Thisted E, Ebbesen F. Malformations, withdrawal manifes- tations, and hypoglycaemia after exposure to valproate in utero. Arch Dis Childhood 1993;69(3, special no):288–91.
   Google Scholar
• Post RM, Leverich GS, Altshuler L, Mikalauskas K. Lithium- discontinuation–induced refractoriness: preliminary obser- vations. Am J Psychiatry 1992;149:1727–9.
   PubMed Web of Science ®Google Scholar
• Post RM, Leverich GS, Pazzaglia PJ, Mikalauskas K, Deni- coff K. Lithium tolerance and discontinuation as pathways to refractoriness. In: Birch NJ, Padgham C, Hughes MS, eds. Lithium in medicine and biology. Carnforth, England: Mar- ius, 1993:71–84.
   Google Scholar
• Bauer M. Refractoriness induced by lithium discontinuation despite adequate serum lithium levels [Letter]. Am J Psychi- atry 1994;151:1522.
   PubMed Web of Science ®Google Scholar
• Maj M, Pirozzi R, Magliano L. Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar pa- tients: prevalence and predictors. Am J Psychiatry 1995; 152:1810–1.
   PubMed Web of Science ®Google Scholar
• Tondo L, Baldessarini RJ, Floris G, Rudas N. Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders. Am J Psychiatry 1997; 154:548–50.
   Google Scholar
• Coryell W, Solomon D, Leon AC, Akiskal HS, Keller MB, Scheftner WA, et al. Lithium discontinuation and subse- quent effectiveness. Am J Psychiatry 1998;155:895–8.
   Google Scholar
• Post RM, Uhde TW, Ballenger JC, Bunney WE Jr. Carbama- zepine, temporal lobe epilepsy, and manic-depressive illness. Adv Biol Psychiatry 1982;8:117–56.
   Google Scholar
• Mandelstam I, Baldessarini RJ. Does prior illness limit re- sponse to lithium treatment? Bipolar Disord [In press].
   Google Scholar
• Baldessarini RJ, Tondo L, Hennen J, Floris G. Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders. Bipolar Disord 1999;1:91–7.
   Google Scholar
• Baldessarini RJ, Tondo L, Hennen J. Latency and episodes before treatment: effects on pretreatment morbidity but not response to lithium maintenance in bipolar I and II disor- ders. Bipolar Disord [In press].
   Google Scholar
• Baldessarini RJ, Tondo L, Hennen J. Treatment delays in bipolar disorders [Letter]. Am J Psychiatry 1999;156:811–2.
   PubMed Web of Science ®Google Scholar
• Post RM. Psychopharmacology of mood stabilizers. In: Buck- ley PF, Waddington JL, eds. Schizophrenia and mood dis- orders: the new drug therapies in clinical practice. Boston: Butterworth-Heinemann, 2000:127–54.
   Google Scholar
• Post RM, Weiss SRB, Leverich GS, Smith M, Zhang LX. Sen- sitization and kindling-like phenomena in bipolar disorder: implications for psychopharmacology. Clin Neurosci Res 2000;1:69–81.
   Google Scholar
• Baldessarini RJ, Tondo L, Floris G, Hennen J. Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients. J Affect Disord 2000;61:13–22.
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text revision. Washing- ton, DC: American Psychiatric Press, 2000.
   Google Scholar
• Centorrino F, Price BH, Tuttle M, Bahk WM, Hennen J, Al- bert M, et al. Electroencephalographic abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry 2002;159:109–15.
   Google Scholar
• Lasser RA, Baldessarini RJ. Thyroid hormones in depressive disorders: a reappraisal of clinical utility. Harvard Rev Psy- chiatry 1997;4:291–305.
   PubMed Web of Science ®Google Scholar
• Siegel AJ, Baldessarini RJ, Klepser MB, McDonald JC. Pri- mary and drug-induced disorders of water homeostasis in psychiatric patients: principles of diagnosis and manage- ment. Harvard Rev Psychiatry 1998;6:190–200.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Tohen M, Tondo L. Maintenance treatment in bipolar disorder [Letter]. Arch Gen Psychiatry 2000; 57:490–2.
   PubMed Web of Science ®Google Scholar
• Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, et al. Efficacy of olanzapine in acute bipolar ma- nia: a double-blind, placebo-controlled study. Arch Gen Psy- chiatry 2000;57:841–9.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamo- trigine monotherapy in outpatients with bipolar I depres- sion. J Clin Psychiatry 1999;60:79–88.
   PubMed Web of Science ®Google Scholar
• Thies-Flechtner K, Mu¨ ller-Oerlinghausen B, Seibert W, Wal- ther A, Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Pharmaco- psychiatry 1996;29:103–7.
   Google Scholar
• Denicoff KD, Smith-Jackson EE, Disney ER, Ali SO, Lev- erich GS, Post RM. Comparative prophylactic efficacy of lith- ium, carbamazepine, and the combination in bipolar disor- der. J Clin Psychiatry 1997;58:470–8.
   Google Scholar
• Greil W, Ludwig-Mayerhofer W, Erazo N, Scho¨chlin C, Schmidt S, Engel RR, et al. Lithium versus carbamazepine in the maintenance treatment of bipolar disorders—a ran- domised study. J Affect Disord 1997;43:151–61.
   PubMed Web of Science ®Google Scholar
• Greil W, Kleindienst N, Erazo N, Mu¨ ller-Oerlinghausen B. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J Clin Psychopharmacol 1998;18:455–60.
   Google Scholar
• Greil W, Kleindienst N. The comparative prophylactic effi- cacy of lithium and carbamazepine in patients with bipolar I disorder. Int Clin Psychopharmacol 1999;14:277–81.
   PubMedGoogle Scholar
• Bowden CL, Swann AC, Calabrese JR, McElroy SL, Morris D, Petty F, et al. Maintenance clinical trials in bipolar disor- der: design implications of the divalproex-lithium-placebo study. Psychopharmacol Bull 1997;33:693–9.
   PubMedGoogle Scholar
• Maj M, Starace F, Nolfe G, Kemali D. Minimum plasma lith- ium levels required for effective prophylaxis in DSM-III bipo- lar disorder: a prospective study. Pharmacopsychiatry 1986; 19:420–3.
   Google Scholar